The Board of Directors of Essilor International met yesterday to approve the financial statements for the six months ended June 30, 2015. The auditors
have performed a limited review of the consolidated financial statements. Their report does not any observations.

Commenting on these results, Hubert Sagnières, Chairman and Chief Executive Officer of Essilor, said: “Our good performance has confirmed the validity of our strategy designed first, to leverage the many interconnections existing between the Prescription Lenses, Sunwear and Online businesses and second, to bring us closer to our end-consumer. The success of our consumer advertising campaigns and our solid growth in developed markets are driving our higher value-added businesses. These good results underscore, once again, the structural growth in our two main markets – vision correction and eye protection – and the potential offered worldwide by our mission, which is ‘to improve lives by improving sight’. Given that these dynamics will remain operative in the second half and that our business is expected to enjoy faster growth, we are confident in our ability to meet our full-year financial targets.”

Since the beginning of the year and around the globe, Essilor has been pursuing its growth model combining innovation and partnerships in its three core businesses: Prescription Lenses, Sunwear and Online. The Company is deploying new products, stepping up investment in direct-to-consumer advertising, leveraging synergies from acquisitions and continually expanding in fast-growing countries, in particular by assertively winning new territories. These initiatives are driving strong growth in its business despite the economic uncertainties that persist in several parts of the world.
First-half operating highlights
First-half 2015 revenue grew 9.4% excluding the currency effect and was driven by the following operational advances:
 Like-for-like revenue growth in the Lenses & Optical Instruments division of 4.7% over six months and of 4.9 % in the second quarter alone.
 The start of the commercial roll-out of several new products, including the EyezenTM lenses designed for a connected life, the Varilux Comfort® 3.0 and Varilux® Physio® 3.0 progressive lenses, the Transitions® XTractiveTM photochromic lenses and the E-SPF® 35 UV-protection index.
 The continuation of the Transitions Optical integration and expansion in photochromic lenses ;
 The ramp-up and success of the consumer media campaigns, which are spurring sales of such
value-added brands as Crizal®, Varilux®, Transitions® and Xperio®.
 The firm growth in developed markets, especially the United States and Europe.
 The robust improvement in domestic sales in the fast-growing countries.
 The improvement in FGX International’s sales in North America in the second quarter.
 The sustained expansion of the Online business and the ongoing reorganization of,
with in particular the adoption of its new commercial identity under ClearlyTM.
 Continued deployment of the partnership strategy, which has given rise to nine new external growth transactions since the beginning of the year, representing aggregate full-year revenue of around €137 million.
The second half is expected to see the sustained ramp-up of a number of growth drivers, including the global deployment of recently-launched products, the impact of direct-to-consumer advertising, the increasing contribution from online sales and the ongoing improvement of FGX International in North America.
As a result, and barring any additional strategic acquisitions, Essilor confirms its full-year 2015 targets: revenue growth of between 8% and 11% excluding the currency effect and in excess of 4.5% on a like- for-like basis; and a contribution from operations1 of at least 18.8% of revenue.
1. Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and
development costs, selling and distribution costs, other operating expenses).
2. Net cash from operating activities excluding change in working capital requirement.
3. The 2014 financial statements have been adjusted for a certain number of non-recurring items arising mainly on the
Transitions Optical,, Costa and Xiamen Yarui Optical acquisitions. The unadjusted financial statements are presented in the First-Half 2015 Condensed Consolidated Financial Statements.